Effect of benralizumab on histopathology and inflammatory signatures in a clinical cohort of eosinophilic esophagitis
Dis Esophagus. 2024 Jul 11:doae031. doi: 10.1093/dote/doae031. Online ahead of print. ABSTRACT A preliminary report from the recent phase 3 trial of benralizumab, a monoclonal …